Last reviewed · How we verify

NCT06601530

Effect of Transversus Thoracic Muscle Plane Block (TTMP) on Analgesia

Completed Phase 4 Last updated 19 September 2024
What this trial tests

Phase 4 trial testing Transversus Thoracic Muscle Plane Block in Coronary Artery Bypass in 46 participants. Completed in 1 October 2022.

Timeline
1 August 2022
Primary endpoint
1 September 2022
1 October 2022

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment46
Start date1 August 2022
Primary completion1 September 2022
Estimated completion1 October 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 18 to 70, any sex, with Coronary Artery Bypass or Anesthesia, Conduction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective and controlled study, the investigators investigated the effect of transversus thoracic muscle plane block (TTMP) on analgesia in patients who undergo coronary artery bypass graft (CABG) surgery with median sternotomy. For this purpose, the investigators aimed to compare the hemodynamic responses to surgical incision and sternotomy and, pain intensity, total analgesic consumption, additional analgesic requirements of the patients in the first 24 hours after extubation under postoperative patient-controlled analgesia (PCA) adminisration.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transversus Thoracic Muscle Plane Block

Trials testing the same drug.

Other recruiting trials for Coronary Artery Bypass

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06601530.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing